Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Perspectives From COPD Subjects on Portable Long-Term Oxygen Therapy Devices.

ALMutairi HJ, Mussa CC, Lambert CTM, Vines DL, Strickland SL.

Respir Care. 2018 Jun 19. pii: respcare.05916. doi: 10.4187/respcare.05916. [Epub ahead of print]

PMID:
29921606
2.

Measurement of Tumor Hypoxia in Patients With Locally Advanced Cervical Cancer Using Positron Emission Tomography with 18F-Fluoroazomyin Arabinoside.

Han K, Shek T, Vines D, Driscoll B, Fyles A, Jaffray D, Keller H, Metser U, Pintilie M, Xie J, Yeung I, Milosevic M.

Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30329-8. doi: 10.1016/j.ijrobp.2018.02.030. [Epub ahead of print]

PMID:
29680257
3.

Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer.

Haynes J, McKee TD, Haller A, Wang Y, Leung C, Gendoo DMA, Lima-Fernandes E, Kreso A, Wolman R, Szentgyorgyi E, Vines DC, Haibe-Kains B, Wouters BG, Metser U, Jaffray DA, Smith M, O'Brien CA.

Clin Cancer Res. 2018 May 1;24(9):2116-2127. doi: 10.1158/1078-0432.CCR-17-1715. Epub 2018 Feb 23.

PMID:
29476017
4.

Colorectal Cancer Screening – Effect on Mortality and Incidence Rate of Colorectal Cancer: Overview of Documentation and International Recommendations [Internet].

Hviding K, Juvet LK, Vines D, Fretheim A.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2008 Oct.

5.

Serial 4DCT/4DPET imaging to predict and monitor response for locally-advanced non-small cell lung cancer chemo-radiotherapy.

Bissonnette JP, Yap ML, Clarke K, Shessel A, Higgins J, Vines D, Atenafu EG, Becker N, Leavens C, Bezjak A, Jaffray DA, Sun A.

Radiother Oncol. 2018 Feb;126(2):347-354. doi: 10.1016/j.radonc.2017.11.023. Epub 2017 Dec 12.

PMID:
29246584
6.

Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models.

Zhang L, Vines DC, Scollard DA, McKee T, Komal T, Ganguly M, Do T, Wu B, Alexander N, Vali R, Shammas A, Besanger T, Baruchel S.

Contrast Media Mol Imaging. 2017 Aug 8;2017:9481276. doi: 10.1155/2017/9481276. eCollection 2017.

7.

Perceived Satisfaction With Long-Term Oxygen Delivery Devices Affects Perceived Mobility and Quality of Life of Oxygen-Dependent Individuals With COPD.

Mussa CC, Tonyan L, Chen YF, Vines D.

Respir Care. 2018 Jan;63(1):11-19. doi: 10.4187/respcare.05487. Epub 2017 Oct 3.

PMID:
28974643
8.

Role of Integrated Pulmonary Index in Identifying Extubation Failure.

Kaur R, Vines DL, Liu L, Balk RA.

Respir Care. 2017 Dec;62(12):1550-1556. doi: 10.4187/respcare.05434. Epub 2017 Sep 5.

PMID:
28874612
9.

Evaluation of Endotracheal Tube Scraping on Airway Resistance.

Scott JB, Dubosky MN, Vines DL, Sulaiman AS, Jendral KR, Singh G, Patel A, Kaplan CA, Gurka DP, Balk RA.

Respir Care. 2017 Nov;62(11):1423-1427. doi: 10.4187/respcare.05391. Epub 2017 Aug 8.

PMID:
28790149
10.

The Effect of Nebulizer Position on Aerosolized Epoprostenol Delivery in an Adult Lung Model.

Anderson AC, Dubosky MN, Fiorino KA, Quintana V, Kaplan CA, Vines DL.

Respir Care. 2017 Nov;62(11):1387-1395. doi: 10.4187/respcare.05344. Epub 2017 Jul 18.

PMID:
28720675
11.

Vibrating Mesh Nebulizer Compared With Metered-Dose Inhaler in Mechanically Ventilated Subjects.

Dubosky MN, Chen YF, Henriksen ME, Vines DL.

Respir Care. 2017 Apr;62(4):391-395. doi: 10.4187/respcare.04823. Epub 2017 Jan 10.

12.

Evaluating the Effectiveness of Written Dry Powder Inhaler Instructions and Health Literacy in Subjects Diagnosed With COPD.

Alsomali HJ, Vines DL, Stein BD, Becker EA.

Respir Care. 2017 Feb;62(2):172-178. doi: 10.4187/respcare.04686. Epub 2016 Dec 27.

13.

Adaptive Dose Escalation using Serial Four-dimensional Positron Emission Tomography/Computed Tomography Scans during Radiotherapy for Locally Advanced Non-small Cell Lung Cancer.

Yap ML, Sun A, Higgins J, Clarke K, Marshall A, Becker N, Le LW, Vines DC, Bezjak A, Bissonnette JP.

Clin Oncol (R Coll Radiol). 2016 Dec;28(12):e199-e205. doi: 10.1016/j.clon.2016.08.011. Epub 2016 Sep 13.

PMID:
27637725
14.

A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.

Han K, Croke J, Foltz W, Metser U, Xie J, Shek T, Driscoll B, Ménard C, Vines D, Coolens C, Simeonov A, Beiki-Ardakani A, Leung E, Levin W, Fyles A, Milosevic MF.

Radiother Oncol. 2016 Sep;120(3):519-525. doi: 10.1016/j.radonc.2016.08.002. Epub 2016 Aug 12.

PMID:
27528120
15.

Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake.

Metran-Nascente C, Yeung I, Vines DC, Metser U, Dhani NC, Green D, Milosevic M, Jaffray D, Hedley DW.

J Nucl Med. 2016 Mar;57(3):361-6. doi: 10.2967/jnumed.115.167650. Epub 2016 Jan 14.

16.

Predicting Radiation Esophagitis Using 18F-FDG PET During Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer.

Mehmood Q, Sun A, Becker N, Higgins J, Marshall A, Le LW, Vines DC, McCloskey P, Ford V, Clarke K, Yap M, Bezjak A, Bissonnette JP.

J Thorac Oncol. 2016 Feb;11(2):213-21. doi: 10.1016/j.jtho.2015.10.006. Epub 2015 Dec 22.

17.

Molecular alterations in the hippocampus after experimental subarachnoid hemorrhage.

Han SM, Wan H, Kudo G, Foltz WD, Vines DC, Green DE, Zoerle T, Tariq A, Brathwaite S, D'Abbondanza J, Ai J, Macdonald RL.

J Cereb Blood Flow Metab. 2014 Jan;34(1):108-17. doi: 10.1038/jcbfm.2013.170. Epub 2013 Sep 25.

18.

A novel minimally invasive technique to create a rabbit VX2 lung tumor model for nano-sized image contrast and interventional studies.

Anayama T, Nakajima T, Dunne M, Zheng J, Allen C, Driscoll B, Vines D, Keshavjee S, Jaffray D, Yasufuku K.

PLoS One. 2013 Jun 28;8(6):e67355. doi: 10.1371/journal.pone.0067355. Print 2013.

19.

Effect of heliox on end-tidal CO2 measurement in healthy adults.

Waugh JB, Gardner DD, Vines DL.

Respir Care. 2013 Nov;58(11):1945-8. doi: 10.4187/respcare.02183. Epub 2013 Apr 30.

20.

Positron-emission tomography imaging of the TSPO with [(18)F]FEPPA in a preclinical breast cancer model.

Vasdev N, Green DE, Vines DC, McLarty K, McCormick PN, Moran MD, Houle S, Wilson AA, Reilly RM.

Cancer Biother Radiopharm. 2013 Apr;28(3):254-9. doi: 10.1089/cbr.2012.1196. Epub 2013 Jan 25.

PMID:
23350894
21.

Sequence dependence of MEK inhibitor AZD6244 combined with gemcitabine for the treatment of biliary cancer.

Xu J, Knox JJ, Ibrahimov E, Chen E, Serra S, Tsao M, Cao P, Vines D, Green DE, Metran-Nascente C, McNamara MG, Hedley DW.

Clin Cancer Res. 2013 Jan 1;19(1):118-27. doi: 10.1158/1078-0432.CCR-12-2557. Epub 2012 Oct 22.

22.

Evaluation of mouse tail-vein injections both qualitatively and quantitatively on small-animal PET tail scans.

Vines DC, Green DE, Kudo G, Keller H.

J Nucl Med Technol. 2011 Dec;39(4):264-70. doi: 10.2967/jnmt.111.090951. Epub 2011 Oct 3.

23.

Liposome contrast agent for CT-based detection and localization of neoplastic and inflammatory lesions in rabbits: validation with FDG-PET and histology.

Zheng J, Allen C, Serra S, Vines D, Charron M, Jaffray DA.

Contrast Media Mol Imaging. 2010 May-Jun;5(3):147-54. doi: 10.1002/cmmi.378.

PMID:
20586032
24.

Efficacy of combining GMX1777 with radiation therapy for human head and neck carcinoma.

Kato H, Ito E, Shi W, Alajez NM, Yue S, Lee C, Chan N, Bhogal N, Coackley CL, Vines D, Green D, Waldron J, Gullane P, Bristow R, Liu FF.

Clin Cancer Res. 2010 Feb 1;16(3):898-911. doi: 10.1158/1078-0432.CCR-09-1945. Epub 2010 Jan 26.

25.

18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.

McLarty K, Fasih A, Scollard DA, Done SJ, Vines DC, Green DE, Costantini DL, Reilly RM.

J Nucl Med. 2009 Nov;50(11):1848-56. doi: 10.2967/jnumed.109.067231. Epub 2009 Oct 16.

26.

Synthesis and preliminary biological evaluations of [18F]-1-deoxy-1-fluoro-scyllo-inositol.

Vasdev N, Chio J, van Oosten EM, Nitz M, McLaurin J, Vines DC, Houle S, Reilly RM, Wilson AA.

Chem Commun (Camb). 2009 Oct 7;(37):5527-9. doi: 10.1039/b913317h. Epub 2009 Aug 11.

PMID:
19753345
27.

Quantification of local tumor response to fractionated radiation therapy for non-Hodgkin lymphoma using weekly 18F-FDG PET/CT imaging.

Keller H, Goda JS, Vines DC, Lockwood G, Tsang R.

Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3):850-8. doi: 10.1016/j.ijrobp.2009.02.061. Epub 2009 Jun 8.

PMID:
19515502
28.

Medication adherence issues in patients treated for COPD.

Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, Sikkema-Ortiz J, Gardner DD, Wilkins RL.

Int J Chron Obstruct Pulmon Dis. 2008;3(3):371-84. Review.

29.

Crystal structures of PI3K-C2alpha PX domain indicate conformational change associated with ligand binding.

Parkinson GN, Vines D, Driscoll PC, Djordjevic S.

BMC Struct Biol. 2008 Feb 29;8:13. doi: 10.1186/1472-6807-8-13.

30.

Quantitative PET comparing gated with nongated acquisitions using a NEMA phantom with respiratory-simulated motion.

Vines DC, Keller H, Hoisak JD, Breen SL.

J Nucl Med Technol. 2007 Dec;35(4):246-51. Epub 2007 Nov 15.

31.

Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys.

Ichise M, Vines DC, Gura T, Anderson GM, Suomi SJ, Higley JD, Innis RB.

J Neurosci. 2006 Apr 26;26(17):4638-43.

32.

Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.

Fujita M, Ichise M, Zoghbi SS, Liow JS, Ghose S, Vines DC, Sangare J, Lu JQ, Cropley VL, Iida H, Kim KM, Cohen RM, Bara-Jimenez W, Ravina B, Innis RB.

Ann Neurol. 2006 Jan;59(1):174-7.

33.

The next generation of respiratory therapists: student recruitment and selection.

Gardner DD, Vines DL.

Respir Care Clin N Am. 2005 Sep;11(3):355-69.

PMID:
16168907
34.

PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.

Toyama H, Ye D, Ichise M, Liow JS, Cai L, Jacobowitz D, Musachio JL, Hong J, Crescenzo M, Tipre D, Lu JQ, Zoghbi S, Vines DC, Seidel J, Katada K, Green MV, Pike VW, Cohen RM, Innis RB.

Eur J Nucl Med Mol Imaging. 2005 May;32(5):593-600. Epub 2005 Mar 25.

PMID:
15791432
35.

Reproducibility of dopamine transporter density measured with 123I-FPCIT SPECT in normal control and Parkinson's disease patients.

Tsuchida T, Ballinger JR, Vines D, Kim YJ, Utsunomiya K, Lang AE, Ichise M.

Ann Nucl Med. 2004 Oct;18(7):609-16.

PMID:
15586635
36.

Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET.

Lu JQ, Ichise M, Liow JS, Ghose S, Vines D, Innis RB.

J Nucl Med. 2004 Sep;45(9):1555-9.

37.

Absolute quantification of regional cerebral glucose utilization in mice by 18F-FDG small animal PET scanning and 2-14C-DG autoradiography.

Toyama H, Ichise M, Liow JS, Modell KJ, Vines DC, Esaki T, Cook M, Seidel J, Sokoloff L, Green MV, Innis RB.

J Nucl Med. 2004 Aug;45(8):1398-405.

38.

Whole-body biodistribution and radiation dosimetry estimates for the PET dopamine transporter probe 18F-FECNT in non-human primates.

Tipre DN, Fujita M, Chin FT, Seneca N, Vines D, Liow JS, Pike VW, Innis RB.

Nucl Med Commun. 2004 Jul;25(7):737-42.

39.

Radiation dosimetry estimates for the PET serotonin transporter probe 11C-DASB determined from whole-body imaging in non-human primates.

Tipre DN, Lu JQ, Fujita M, Ichise M, Vines D, Innis RB.

Nucl Med Commun. 2004 Jan;25(1):81-6.

PMID:
15061269
40.

Evaluation of anesthesia effects on [18F]FDG uptake in mouse brain and heart using small animal PET.

Toyama H, Ichise M, Liow JS, Vines DC, Seneca NM, Modell KJ, Seidel J, Green MV, Innis RB.

Nucl Med Biol. 2004 Feb;31(2):251-6.

PMID:
15013491
41.

Care of the ventilator circuit and its relation to ventilator-associated pneumonia.

Hess DR, Kallstrom TJ, Mottram CD, Myers TR, Sorenson HM, Vines DL; American Association for Respiratory Care.

Respir Care. 2003 Sep;48(9):869-79.

42.

Evaluation of 2 scatter correction methods using a striatal phantom for quantitative brain SPECT.

Vines DC, Ichise M, Liow JS, Toyama H, Innis RB.

J Nucl Med Technol. 2003 Sep;31(3):157-60.

43.

Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4).

Razzaq TM, Bass R, Vines DJ, Werner F, Whawell SA, Ellis V.

J Biol Chem. 2003 Oct 24;278(43):42679-85. Epub 2003 Aug 11.

44.

Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.

Kim YJ, Ichise M, Ballinger JR, Vines D, Erami SS, Tatschida T, Lang AE.

Mov Disord. 2002 Mar;17(2):303-12.

PMID:
11921116
45.
46.

Normal patterns on 99mTc-ECD brain SPECT scans in adults.

Tanaka F, Vines D, Tsuchida T, Freedman M, Ichise M.

J Nucl Med. 2000 Sep;41(9):1456-64.

47.

Evaluation of differential magnification during brain SPECT acquisition.

Vines DC, Ichise M.

J Nucl Med Technol. 1999 Sep;27(3):198-203.

48.

External radioactive reference markers in SPECT imaging of the dopamine system.

Vines DC, Ivo BD, Ballinger JR, Ichise M.

J Nucl Med Technol. 1999 Jun;27(2):112-6.

49.

SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD.

Ichise M, Kim YJ, Ballinger JR, Vines D, Erami SS, Tanaka F, Lang AE.

Neurology. 1999 Apr 12;52(6):1206-14.

PMID:
10214745
50.

Functional morphometry of the striatum in Parkinson's disease on three-dimensional surface display of 123I-beta-CIT SPECT data.

Ichise M, Kim YJ, Erami SS, Ballinger JR, Vines D, Tanaka F, Lang AE.

J Nucl Med. 1999 Apr;40(4):530-8.

Supplemental Content

Support Center